Stopped trading. Fund positions aren't valued until we confirm what happened.

ALEXION PHARMACEUTICALS INC
ALXN (ALEXION PHARMACEUTICALS INC) is held by 2 institutional investors as of Q3 2021. Top institutional shareholders: Orion Portfolio Solutions, LLC ($423,000), Barclays plc ($22,000).
No verdict yet — fewer than 2 funds hold ALXN.
Top Holders
Showing 1-20 of 246
Continue exploring
Similar stocks
Questions investors ask about ALXN
Who owns ALXN?
2 institutional investors held ALXN on September 30, 2021, led by Orion Portfolio Solutions, LLC ($423,000) and Barclays plc ($22,000).
How many hedge funds hold ALXN?
2 institutional investors reported ALXN in their 13F filings for the quarter ended September 30, 2021, $445,000 in all.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer